Long-term cost-utility analysis of remote monitoring of older patients with pacemakers: the PONIENTE study

BMC Geriatrics

Table 5 Utility values, quality-adjusted life years (QALYs), and cost per patient along the five-year study period

Variables	All			Conventional Monitoring group			Remote Monitoring group			Difference per patient
Variables	n	Mean	SD	n	Mean	SD	n	Mean	SD	Mean dif.	p-value
EQ5 DM00	55	0.71	0.36	34	0.72	0.36	21	0.70	0.38	0.02	0.795
EQ5 DM12	55	0.85	0.32	34	0.82	0.37	21	0.90	0.19	−0.08	0.301
EQ5 DM60	55	0.73	0.37	34	0.77	0.36	21	0.68	0.39	0.09	0.363
QALYM60	55	3.48	1.47	34	3.58	1.45	21	3.31	1.52	0.27	0.515
Cost/QALYM60 (€)	55	195.64	515.73	34	177.08	357.90	21	225.69	710.80	−48.61	0.773
Cost/patient (€)	55	325.28	142.91	34	356.62	144.12	21	274.53	128.45	82.10	0.033
ICER	–	–	–	–	–	–	–	–	–	301.16	–

EQ–5D M12 EuroQoL five-dimensional questionnaire after 12 months; EQ–5D M60 EuroQoL five-dimensional questionnaire after 5 years; QALYM60 quality adjusted life years after 5 years; ICER incremental cost-effectiveness ratio (ICER), calculated as the difference in the expected cost per patient (€) divided by the difference in the QALY produced by the two interventions (CM and RM)
3% discount rate applied to annual costs and QALYs

ISSN: 1471-2318